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Abstract
Background: The increasing prevalence and impact of obstructive lung diseases and new insights, reflected in 
clinical guidelines, have led to concerns about the diagnosis and therapy of asthma and COPD  in primary care. In 
Germany diagnoses written in medical records are used for reimbursement, which may influence physicians' 
documentation behaviour. For that reason it is unclear to what respect ICD-l0 codes reflect the real problems 
of the patients in general practice. The aim of this study was to assess the appropriateness of the recorded 
diagnoses and to determine what diagnostic information is used to guide medical treatment.
M ethods: All patients with lower airway symptoms (n = 857) who had attended six general practices between 
January and June 2003 were included into this cross sectional observational study. Patients were selected from 
the computerised medical record systems, focusing on ICD-l0-codes concerning lower airway diseases (J20-J22, 
J40-J47, J98 and R05). The performed diagnostic procedures and actual medication for each identified patient were 
extracted manually. Then we examined the associations between recorded diagnoses, diagnostic procedures and 
prescribed treatment for asthma and COPD  in general practice.
Results: Spirometry was used in 30% of the patients with a recorded diagnosis of asthma and in 58% of the 
patients with a recorded diagnosis of COPD. Logistic regression analysis showed an improved use of spirometry 
when inhaled corticosteroids were prescribed for asthma (OR = 5.2; CI 2.9-9.2) or COPD  (OR = 4.7; CI 2.0-
l0.6). Spirometry was also used more often when sympathomimetics were prescribed (asthma: OR = 2.3; CI l.2- 
4.2; COPD: OR = 4.l; CI l.8-9.4).
Conclusions: This study revealed that spirometry was used more often when corticosteroids or 
sympathomimetics were prescribed. The findings suggest that treatment was based on diagnostic test results 
rather than on recorded diagnoses. The documented ICD-l0 codes may not always reflect the real status of the 
patients. Thus medical care for asthma and COPD  in general practice may be better than initially found on the 
basis of recorded diagnoses, although further improvement of practice patterns in asthma and COPD  is still 
necessary.
Open Access
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Background
There is broad agreement between existing guidelines for 
asthma [1-4] regarding diagnostic procedures, patient 
education and medical treatment [5]. The statements for 
chronic obstructive pulmonary disease (COPD) [6-8] are 
also consistent, despite the lack of evidence for some rec­
ommendations [9]. However, it has been shown previ­
ously that the management of these diseases in practice 
was not fully consistent with the guidelines [10-12], 
which may be related to the variety of views on the treat­
m ent of these conditions [13,14]. Furthermore, the 
knowledge about the diseases is changing rapidly and the 
management has become more complex [15,16]. Many 
patients with asthma or COPD are managed in primary 
care and it is important to optimise the treatment given 
the prevalence and impact [17].
However, it remains difficult to draw a clear picture of 
management of obstructive lung diseases in primary care 
since the diagnoses of asthma and COPD often have not 
been separated in many surveys [7]. This could be due to 
some diagnostic and therapeutic overlap between these 
both diseases. Especially in primary care it is difficult to 
distinguish both entities when the symptoms are pre­
sented in an early stage [18]. In particular the treatment 
response in this stage often seem to be no t strongly related 
to the stated diagnoses [19,20], and also the treatment 
response of COPD in the long term course is disappoint­
ing [21].
Furthermore, systematic registration of diseases in pri­
mary care are often hampered by missing of recorded 
diagnoses [22] or discrepancies between diagnoses and 
prescribed medications [23]. A specific problem for health 
services research and performance assessment in Germany 
might be that diagnoses saved in medical records are used 
for reimbursement. For that reason it is unclear to what 
respect ICD-10 codes reflect the real problems of patients 
in general practice. It may be possible that physicians 
enter diagnoses in their records to get reimbursement, but 
use other information such as results of diagnostic tests 
for treatment. Empirical evidence on this phenom enon is 
limited, bu t its existence would complicate the assessment 
of practice patterns.
The aim of this study was to assess the appropriateness of 
the recorded diagnoses and to determine what diagnostic
Table 1: Baseline characteristics
information is used to guide medical treatment. For this 
purpose we analysed associations between recorded diag­
noses, diagnostic procedures and medical treatment 
regarding asthma and COPD in general practice.
Methods 
Study design
A cross-sectional observational study was performed in six 
computerised general practices with a total of eleven GPs 
in the Rhine-Neckar region in Southern Germany.
Setting and study subjects
All patients who had attended their physicians with 
asthma, COPD or other lower airway diseases from Janu­
ary until June 2003 were included in the study.
Ethical approval
The study was approved by the Medical Ethics Committee 
of the University of Heidelberg.
Procedure for selection o f subjects
Patients were identified by searching the electronic files 
for documented diagnoses concerning lower airway dis­
eases within the time frame. The data were evaluated sys­
tematically according to the international classification of 
diseases (ICD-10). In detail, the practice software was 
checked for the ICD-10-codes of the chapter "chronic 
lower airway disease": J40 (bronchitis, not specified as 
acute or chronic), J41 (simple and mucopurulent chronic 
bronchitis), J42 (unspecified chronic bronchitis), J43 
(emphysema), J44 (chronic obstructive pulmonary dis­
ease), J45 (asthma), J46 (status asthmaticus), J47 (bron­
chiectasis). Additionally, the ICD-10-codes J98 (diseases 
of bronchus, not elsewhere classified) and R05 (cough / 
bronchial hyperreactivity), and the repeated documenta­
tion of ICD-10-codes belonging to the chapter "acute 
lower airway disease" were extracted in order to detect 
potentially existing but not detected asthma or COPD. 
The chapter "acute lower airway disease" includes the 
diagnoses J20 (acute bronchitis), J21 (acute bronchiolitis) 
and J22 (unspecified acute lower respiratory infection).
The performed diagnostic procedures and the actual m ed­
ication for each identified patient were extracted and doc­
um ented manually by two independent scientific fellows 
(L.G., I.M.) of the department. The variables of the used 
protocol for documentation are listed in table 2.
O vera ll (n = 857) A s th m a  (n = 255) C O P D  (n  = 112) A s th m a  + C O P D  (n = 25) O th e r  (n  = 465)
age
sex
41.84 ± 22.18 
(min 1 ; max 97) 
m 385; f 472
36.48 + 21.00 
(min 1; max 88) 
m 121; f 134
56.28 + 18.38 
(min 21; max 92) 
m 55; f 57
46.23 + 19.16 41.06 + 22.32 
(min 26; max 71) (min 1; max 97) 
m 15; f 10 m 194; f 271
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Table 2: Perform ed diagnostics and docum ented diagnoses
A s th m a  (n = 255) C O P D  (n  = 112) O th e r  (n = 465)
Perfo rm ed  diagnostics n % O R 95% C I n % O R 95% C I n % O R 95% C I
Medical history only 42 16.5 0.11 0.07-0.15 33 29.3 0.31 0.20-0.46 338 72.7 10.9 7.89-15.02
Medical history and trial of medication 57 22.4 8.11 4.68-14.08 6 5.4 0.51 0.23-1.13 12 2.6 0.14 0.07-0.26
Medical history and spirometry 77 30.2 1.30 0.99-1.72 65 58.1 4.38 2.99-6.40 90 19.4 0.37 0.27-0.50
Medical history and PEF-measurement 79 31.0 7.57 4.93-1 1.60 8 7.1 0.81 0.47-1.40 25 5.4 0.18 0.11-0.28
Additional bronchial challenge test 18 3.9 1.35 0.73-2.48 24 21.4 6.74 3.66-12.42 1 0 0.16 0.08-0.35
Additional chest X-ray 34 13.3 0.88 0.58-1.31 42 37.5 4.06 2.67-6.19 48 10.3 0.44 0.30-0.65
Analysis
Every ICD10-code specified above was extracted and writ­
ten down, at maximum up to three I CD- 10-Codes per 
patient were found. The diagnoses were clustered into 
three groups: asthma, COPD, and other lower airway dis­
eases. If more than one diagnosis was documented, 
asthma (J45) or COPD (J44) were extracted as the leading 
diagnosis.
The ICD-10 group J43 (emphysema) was included into 
the ICD-10 group J 44 (COPD). The ICD-10 groups other 
than J45 (asthma), J44 or J43 were merged into the group 
"other lower airway diseases".
The performed diagnostic procedures were extracted m an­
ually. Four ways of making diagnoses have been found in 
the records: 1. taking medical history only, 2. taking med­
ical history plus trial of medication, 3. taking medical his­
tory and performing spirometry, 4. taking medical history 
plus single measurement of PEF. The additional perform­
ance of bronchial challenge testing and chest X-ray was 
documented, too.
Baseline data were evaluated descriptively. The t-test was 
used to detect differences of age. Linear logistic regression 
was used to test relationships between diagnosing asthma 
or COPD and the performed diagnostics. The relation 
between prescribing patterns and performed diagnostics 
was also examined with logistic regression analysis.
Results
Overall, 8765 patients attended the practices within the 
time frame. 857 (9,8%) patients had lower airways dis­
eases (385 male, 472 female).
A total of 255 (2.9% of 8765) had the recorded diagnosis 
of asthma and 112 (1.3% of 8765) had COPD (107 with 
J44 = COPD, 5 with J43 = emphysema). A combination of 
asthma and COPD was documented in 25 (0.2% of 8765) 
cases.
The 465 (5.3% of 8765) patients with "other lower airway 
diseases" included seven cases with acute bronchitis (J20), 
none with acute bronchiolitis (J21), one case with unspec­
ified acute lower respiratory infection (J22), 251 (2.9% of 
8765) cases with no t specified bronchitis (J40), 38 with 
simple and mucopurulent chronic bronchitis (J41), 57 
with unspecific chronic bronchitis (J42), one with bron­
chiectasis (J47), seven with diseases of bronchus, not clas­
sified (J98), 103 (1.2% of 8765) with cough / bronchial 
hyperreactivity (R05), Patients with COPD were signifi­
cantly older than those with asthma or other lower airway 
diseases. There was no case of twofold documentation of 
"acute lower airway disease" (J20 - J22) within the time 
frame. The details regarding the patient population are 
described in table 1.
Diagnostics
Table 2 shows the performed diagnostic procedures. 
Spirometry was performed in 30% of the patients with 
recorded asthma. A high am ount was diagnosed with 
'medical history and single measurement of peak expira­
tory flow' (31%), and 22% of cases fell into the category 
of medical history taking plus trial of medication (= diag­
nosing by therapy). This implies that the physician gives 
sympathomimetics in suspected asthma. If the patient 
feels better, the diagnosis 'asthma' is made.
In about 17% the diagnosis asthma was made only on the 
basis of medical history
Spirometry was performed in 58% of the cases with 
recorded COPD. In 29% the diagnosis was made only by 
medical history. A small percentage (7%) was diagnosed 
by history taking and PEF-measurement and 5% by diag­
nosing by therapy.
Concerning the other lower airway diseases, spirometry 
was done in 19% in order to exclude asthma or COPD. 
These diagnoses were made mainly on the basis of medi­
cal history (73%).
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Table 3: Relationship between perform ed diagnostis. actual trea tm en t and docum ented diagnoses
Perfo rm ed  diagnostics and actual 
trea tm en t
A s th m a  (n  =: 255) C O P D  (n = 112) O th e r  (n = 465)
n % O R 95% C I n % O R 95% C I n % O R 95% C I
Sym pathom im etics (n = 167; 65.5%) (n = 47; 42.0%) (n = 36; 7.7%)
Medical history only 9 3.5 0.22 0.10-0.51 7 6.3 1.35 0.56-3.26 |0 2.2 4.97 2.05-12.02
Medical history and trial of medication 52 20.4 7.99 3.06-20.85 4 3.6 2.93 0.51-16.71 8 1.7 31.48 8.95-111.2
Medical history and spirometry 60 23.5 2.28 1.24-4.18 36 32.1 4.06 1.77-9.35 |4 3.0 3.10 1.51-6.36
Medical history and PEF-measurement 46 18.0 0.67 0.43-1.07 0 0 0 0-0 4 1.0 2.39 0.77-7.36
Additional bronchial challenge test 12 4.7 3.51 0.77-16.04 9 8.0 1.16 0.44-3.08 0 0 0.01 0-I09
Additional chest X-ray 22 8.6 1.02 0.48-2.17 22 19.6 1.98 0.91-4.31 6 1.0 1.91 0.75-4.86
C orticostero ids (n  = 96; 37.6%) (n = 52; 46.4%) (n = 28; 6.0%)
Medical history only 4 1.6 0.23 0.08-0.66 9 8.0 2.22 0.85-5.78 5 1.0 2.37 0.78-7.23
Medical history and trial of medication 20 7.8 0.91 0.49-1.68 3 2.7 1.16 0.22-6.03 5 1.05 13.99 4.1 1-47.64
Medical history and spirometry 49 19.2 5.17 2.91-9.19 40 35.7 4.67 2.05-10.64 |5 3.2 6.05 2.72-13.45
Medical history and PEF-measurement 23 9.0 0.58 0.33-1.02 0 0 0 0-14 x |04 3 1.0 2.26 0.63-8.04
Additional bronchial challenge test 9 3.5 3.30 1.07-10.17 16 14.3 6.22 1.93-20.11 0 0 0.00 0-0
Additional chest X-ray 16 6.3 1.63 0.79-3.37 29 25.9 4.56 2.00-10.38 |0 2.2 6.19 2.65-14.47
C rom og lyca te (n  = 91; 35.7%) (n = 16; 14.3%) (n = 39; 8.4%)
Medical history only 9 3.5 0.16 0.07-0.37 1 1.0 0.23 0.05-1.02 2| 4.5 12.02 4.93-29.29
Medical history and trial of medication 24 9.4 1.52 0.83-2.79 0 0 0.00 0-1.6 x I018 4 1.0 6.16 1.77-21.51
Medical history and spirometry 23 9.0 0.74 0.42-1.32 10 8.9 1.07 0.40-2.86 |0 2.2 1.70 0.89-3.25
Medical history and PEF-measurement 35 13.7 1.74 1.01-3.00 5 4.5 14.1 2.96-67.18 4 1.0 2.17 0.71-6.65
Additional bronchial challenge test 5 2.0 1.06 0.34-3.26 4 3.6 1.67 0.48-5.83 | 0 1.62 0.19-13.54
Additional chest X-ray 9 3.5 0.65 0.29-1.46 5 4.5 0.73 0.23-2.25 8 1.7 2.58 1.1 1-6.01
The associations between recorded diagnoses and diag­
nostic procedures are calculated by binary logistic regres­
sion (also in table 2). The higher the odds ratio (OR) the 
higher is the positive association between the variables. 
Patients with the combined diagnosis of asthma and 
COPD were not included into the analysis. An odds ratio 
smaller than one means that there is a negative associa­
tion between those variables. Significant results are bold.
The logistic regression showed that the diagnosis asthma 
was often based only on single measurement of PEF (OR
7.6) or 'trial of medication' (OR 8.1). The use of spirome­
try was not significantly associated with the recorded diag­
nosis asthma.
Concerning the recorded diagnosis of COPD, 'trial of 
medication' was not associated significantly. Instead, the 
recorded diagnosis was based on spirometry (OR 4.4). 
Bronchial challenge testing was used to exclude asthma 
(OR 6.7). Also chest X-ray showed a significant associa­
tion with the recorded diagnosis of COPD (OR 4.1).
The recording of other lower airway diseases was mainly 
based on the medical history (OR 10.9), the other diag­
nostic procedures are used only in few cases (OR < 1).
Prescriptions
The documentation of the prescribed medication showed 
that 66% of patients with asthma and 42% with COPD 
received sympathomimetics (table 3). 38% of the asthma 
patients received inhaled corticosteroids, whereas 46% of 
the patients with COPD were treated with inhaled corti­
costeroids. Cromoglycate was given in 36% of patients 
with asthma and 14% of COPD.
Only a small am ount of patients with 'other lower airway 
diseases' received anti-obstructive medicine (6-8% ).
The logistic regression showed that sympathomimetics 
were given in asthma when having shown efficacy (trial of 
medication) (OR 8.0) or when spirometry was performed 
(OR 2.3). Therapy with corticosteroids was significantly 
associated with spirometry (OR 5.2) and bronchial chal­
lenge testing (OR 3.3).
Treatment of COPD with sympathomimetics was signifi­
cantly associated with the use of spirometry (OR 4.1). 
Inhaled corticosteroids were also given more often when 
spirometry (OR 4.7) and Chest X-ray (OR 4.6) had been 
performed. Bronchial challenge testing was used to 
exclude asthma (OR 6.2).
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In asthma as well as in COPD corticosteroids are not pre­
scribed only by trial of medication and are not given after 
making the diagnosis only by medical history.
Prescribing of cromoglycate was associated with PEF 
measurement in both asthma and COPD (OR 1.7 respec­
tively 14.1)
Treatment of the other lower airway diseases with sym- 
pathomimetics respectively corticosteroids was mainly 
associated with testing the efficacy of therapy (OR 31.5 
respectively 14.0). The prescription is lower associated 
with spirometry (OR 3.1 respectively 6.1) or x-ray (OR 1.9 
respectively 6.2). Cromoglycates were given mostly on the 
basis of 'taking medical history only' (OR 12.0) and trial 
of medication (OR 6.2).
Discussion
Although guidelines recommend the use of spirometry, 
this was used in only in 30% of the patients with a 
recorded diagnosis of asthma and in 58% of the patients 
with a recorded diagnosis of COPD. A high number of 
recorded diagnoses of asthma and COPD were insuffi­
ciently diagnosed by PEF-measurement, medical history 
and diagnosing by therapy. On the first sight, patients 
with asthma seem to be treated insufficiently with anti­
inflammatory therapy and patients with COPD seemed to 
be over-treated with steroids.
However, further analysis showed a high association 
between prescribed corticosteroids and sympathomimet- 
ics as long term medication and performed diagnostic 
procedures. This improvement of diagnostic investigation 
when potential harmful drugs are given demonstrates that 
treatment of asthma and COPD by the GPs may be more 
consistent with guidelines than other studies have found 
[10,13]. This hypothesis is facilitated by the fact, that cro­
moglycates seem to be administered if there was diagnos­
tic uncertainty, as there was no significant association 
between performing spirometry and making diagnoses in 
those cases.
According to this, our study shows that a deeper look 
insight with analysis of diagnoses together with 
performed diagnostics and medication could prove a bet­
ter care for people with obstructive airway diseases than a 
single analysis of the documented diagnoses. As a conclu­
sion, ICD-10 codes seem not to be able to reflect the work 
in primary care, in particular if the difficulties of the diag­
nostic and therapeutic differentiation between asthma 
and COPD in earlier stages are taken into account [18,20].
Therefore it seems that the documented diagnosis due to 
ICD-10 often serves as a 'working hypothesis'. The needs 
of family physicians for practice and research would be
best met by the International Classification of Primary 
Care (ICPC-2) [24], but the general practitioners in Ger­
many are politically obliged to record ICD-10 diagnoses 
to get reimbursement. As the documentation of the reason 
of encounter is restricted in these terms of ICD-codes 
there could be some necessity to assign diagnoses 
although they do not match with the real status of the 
patient. This makes the recorded diagnoses unreliable, 
sometimes resulting in apparently poor coherence 
between medication and diagnoses, and this leads to dif­
ficulties in drawing valid conclusions on the quality of 
primary care.
Another critical point is, that the 'trial of medication' as a 
'fact of life in primary care' could implicate a patients' per­
ception of improvement which could lead the doctor to 
perpetuate the therapy, thus resulting in over-prescribing 
accompanied by an avoidable risk of side-effects. Espe­
cially this 'trial of medication' may reflect diagnostic 
uncertainty in general practice, which must normally have 
consequences for the classification and labelling. In 
absence of a reasonable classification system the GPs are 
forced to hide this uncertainty by documenting diagnoses 
in ICD-10-codes. As a result, GPs could feel the uncer­
tainty nevertheless, but start seeing it as a personal short­
coming rather than a reality of medicine. Therefore this 
exaggeration of 'labelling with ICD-10' could also con­
strain a systematic quality improvement in diagnostic per­
formance in primary care.
The strength of the study was the detailed analysis with 
manual extraction and documentation of performed diag­
nostics and actual medication of each identified patient. 
As the ICD-10 classification made it difficult to identify 
patients with obstructive airway diseases in junction with 
performed diagnostics and therapy we searched all 
records manually. Because of this complexity the study 
had the limitation that the number of GPs was small, 
which reduces the generalisability of the descriptive find­
ings, although the estimates of associations are less sensi­
tive for this problem.
The prevalence of asthma and COPD in this German sam­
ple of general practice seems to be low compared to the 
prevalence of about 5% in studies of other countries [25­
27]. One explanation might be the high doctor-patient 
contact rate in Germany that decreases the prevalence of 
severe diseases in general practice.
Conclusions
The conclusion of this study is that performance assess­
ment should take the reliability problems of recorded 
diagnoses into account, especially if the ICD-10 classifica­
tion is used. A more detailed analysis may be necessary for 
adequate evaluation of primary care, consequential point­
Page 5 of 6
(page number not for citation purposes)
BMC Health Services Research 2005, 5:11 http://www.biomedcentral.eom/1472-6963/5/11
ing out to the fact, that treatment of obstructive airways 
diseases by the GP's may be more consistent with guide­
lines than other studies have found. Despite these find­
ings improvement of diagnostic performance in general 
practice is necessary, because a routine use of spirometry 
is of growing importance against the background of the 
increasing prevalence of obstructive airway diseases.
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